% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

  • bridgelight bridgelight Mar 4, 2013 3:50 AM Flag

    BLFS – the most advanced company for biopreservation media products!

    Zacks small cap research - Demand for biopreservation media is estimated to grow at an
    annual rate of almost 20% over the next several years,
    largely driven by rapid growth of the emerging field of
    regenerative medicine (including cell therapy and tissue
    engineering). BioLife's strategy is to build greater visibility
    and awareness of the benefits of their biopreservation
    products compared to the "home-brews" that currently
    dominate the market. Meanwhile, the company's contract
    manufacturing business, which is expected to generate
    ~$2.4MM in revenue in 2012 as a result of the signing if a key
    customer during 2011, is expected to provide a source of
    near-term revenue and cash flow to help fund the further
    development and commercialization of the biopreservation
    media business, which is expected to provide the bulk of
    revenue and drive earnings for the long-term. Moving our
    price target from $0.50 to $0.70.

    Sentiment: Buy

158.51+1.28(+0.81%)Oct 21 4:00 PMEDT